AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Business of Dermatology and Medicine: What Dermatologists Should Know

Description

The presentation discussed the intricate relationship between the business of dermatology and medicine, highlighting key aspects important for dermatologists to understand. Held at the University of Miami, the speaker, who has both clinical and business experience, emphasized that medicine encompasses elements of business, including consumer satisfaction, branding, and legal concerns. Various challenges in the healthcare system were addressed, such as high U.S. healthcare spending with subpar outcomes compared to other developed nations and the oligopolistic nature of pharmaceutical companies contributing to inflated drug prices. The discussion included the shifting dynamics in medical practice, with fewer physicians working independently and an increasing trend towards employment in larger groups and academic settings. Although this shift is accompanied by a rise in telemedicine and technological advancements like AI, concerns around patient care, the physician-patient relationship, and the ethics of practice remain paramount. The rising influence of private equity in dermatology, particularly due to lucrative cosmetic procedures, was analyzed alongside the evolving patient demographics and their need for diverse representation in research. The speaker concluded that understanding the business side of medicine is vital for dermatologists to thrive in an industry poised for considerable transformation.

View more

Conclusions

  • The business of medicine, particularly in dermatology, necessitates an understanding of branding, innovation, and efficient operations to succeed.
  • Despite high healthcare expenditures in the U.S., patient outcomes do not reflect this investment, emphasizing the need for systemic change.
  • The increasing costs of pharmaceuticals and the oligopoly in the industry significantly impact consumer access and healthcare costs.
  • The healthcare system is shifting towards value-based models, necessitating dermatologists to adapt to new reimbursement strategies.
  • The trend of consolidation in dermatology practices is driven by economic pressures and the declining number of independent practitioners.
  • Technological advancements, especially in artificial intelligence and telemedicine, are transforming diagnostic and treatment methods in dermatology.
  • Ignoring the business aspects of medicine can jeopardize the sustainability and success of medical practices.
  • Patients have a desire for shared decision-making, highlighting the importance of the patient-physician relationship in healthcare delivery.
  • Legal issues, including malpractice concerns, continue to have profound implications on healthcare practices.
  • Getzen, Thomas E. 2013. Health Economics and Financing, 5th Edition, New York, New York: John Wiley and Sons, Inc.
  • Glynn EA, Asch SM, Adams J et al. The Quality of Health Care Delivered to Adults in the United States. NEngl J Med. 2003;348:2635-2645.
  • Sager A, Socolar D. Data brief No. 8: Health costs absorb one-quarter of economic growth, 2000-2005. Boston, MA: Boston University School of Public Health, 2005
  • Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 2015; 151(10):1081-1086.
  • Cancer Facts and Figures 2018. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed May 3, 2018.
  • Stern, RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010; 146(3):279-282.
  • The Lewin Group, Inc. The Burden of Skin Diseases 2005. Prepared for the Society for Investigative Dermatology, Cleveland, OH, and the American Academy of Dermatology Assn., Washington, DC, 2005.
  • Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2014; 104(4):e69-e74.
  • McMains, V. (2016). John Hopkins study suggests medical errors are third-leading cause of death in U.S. Johns Hopkins HUB. Retrieved https://hub.jhu.edu/2016/05/03/medical-errors-thirdleading-cause-of-death/
  • Hadeler, E, Gitlow, H, Nouri, K. Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review. Arch Dermatol Res 2020.
  • American Medical Association. AMA Physician Masterfile (December 2019).
  • Gronbeck C, Kodumudi V, Brodell RT, Grant-Kels JM, Mostow EN, Feng H. Dermatology workforce in the United States - Part 1: Overview, transformations, and implications [published online ahead of print, 2022 Jul 3]. J Am Acad Dermatol. 2022;S0190-9622(22)02240-X. doi:10.1016/j.jaad.2022.06.1191
  • Sachdeva M, Price KN, Hsiao JL, Shi VY. Gender and rank salary trends among academic dermatologists. Int J Womens Dermatol. 2020;6(4):324-326. Published 2020 May 13. doi:10.1016/j.ijwd.2020.05.005